学术咨询服务,正当时...... 期刊天空网是可靠的职称论文发表专业学术咨询服务平台!!!

大类学科: 不限 医学 生物 物理 化学 农林科学 数学 地学天文 地学 环境科学与生态学 综合性期刊 管理科学 社会科学 查看全部热门领域

中科院分区: 不限 1区 2区 3区 4区

期刊收录: 不限 SCI SCIE

Oncotargets And Therapy

Oncotargets And Therapy
期刊全称:Oncotargets And Therapy
简称:ONCOTARGETS THER
ISSN:1178-6930
ESSN:1178-6930
研究方向:BIOTECHNOLOGY & APPLIED MICROBIOLOGY - ONCOLOGY
投稿咨询

免费咨询 2023最新分区

Oncotargets And Therapy英文简介

OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer.

The journal is characterized by the rapid reporting of high-quality original research, basic science, reviews and evaluations, expert opinion and commentary that shed novel insight on a cancer or cancer subtype.

Specific topics covered by the journal include:

-Novel therapeutic targets and innovative agents

-Novel therapeutic regimens for improved benefit and/or decreased side effects

-Early stage clinical trials

Further considerations when submitting to OncoTargets and Therapy:

-Studies containing in vivo animal model data will be considered favorably.

-Tissue microarray analyses will not be considered except in cases where they are supported by comprehensive biological studies involving multiple cell lines.

-Biomarker association studies will be considered only when validated by comprehensive in vitro data and analysis of human tissue samples.

-Studies utilizing publicly available data (e.g. GWAS/TCGA/GEO etc.) should add to the body of knowledge about a specific disease or relevant phenotype and must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Bioinformatics studies must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Single nucleotide polymorphism (SNP) studies will not be considered.

Oncotargets And Therapy中文简介

《Oncotargets And Therapy》是一本由DOVE MEDICAL PRESS LTD出版商出版的专业医学期刊,该刊创刊于2008年,刊期1 issue/year,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 4区,小类学科:生物工程与应用微生物 3区;肿瘤学 4区;在JCR(Journal Citation Reports)分区等级为Q2。该刊发文范围涵盖生物工程与应用微生物等领域,旨在及时、准确、全面地报道国内外生物工程与应用微生物工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为4.345,平均审稿速度较慢,6-12周。

中科院分区最新升级版(当前数据版本:2021年12月最新升级版)

大类学科 分区 小类学科 分区 Top期刊 综述期刊
医学 4区 BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 ONCOLOGY 肿瘤学 3区 4区

JCR分区(当前数据版本:2021-2022年最新版)

JCR分区等级 JCR所属学科 分区 影响因子
Q2 ONCOLOGY Q2 4.345
BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q2

期刊指数

影响因子 h-index Gold OA文章占比 研究类文章占比 OA开放访问 平均审稿速度
4.345 44 97.03% 84.15% 开放 较慢,6-12周

IF值(影响因子)趋势图


专家解答 课题、SCI/EI/SSCI怎么写?

对接专家,全程指导

免费咨询 >